INSULIN-LIKE GROWTH-FACTOR-I REGULATES CELL-PROLIFERATION IN THE DEVELOPING INNER-EAR, ACTIVATING GLYCOSYL-PHOSPHATIDYLINOSITOL HYDROLYSIS AND FOS EXPRESSION

Citation
Y. Leon et al., INSULIN-LIKE GROWTH-FACTOR-I REGULATES CELL-PROLIFERATION IN THE DEVELOPING INNER-EAR, ACTIVATING GLYCOSYL-PHOSPHATIDYLINOSITOL HYDROLYSIS AND FOS EXPRESSION, Endocrinology, 136(8), 1995, pp. 3494-3503
Citations number
36
Categorie Soggetti
Endocrynology & Metabolism
Journal title
ISSN journal
00137227
Volume
136
Issue
8
Year of publication
1995
Pages
3494 - 3503
Database
ISI
SICI code
0013-7227(1995)136:8<3494:IGRCIT>2.0.ZU;2-7
Abstract
The role of insulin-like growth factors (IGF) was investigated during the early development of the inner ear. IGF-I stimulated growth of oti c vesicles that were isolated and cultured in vitro. IGF-I induced DNA synthesis, increased cell number, and mitotic rate in a dose-dependen t manner at concentrations between 0.1-10 nM. IGF-II also induced grow th but with a lower potency, whereas insulin had no effect. In the pre sence of IGF-I, otic vesicles developed from stage 18 to stage 21 in 2 4-h cultures, mimicking the normal mitotic pattern and morphogenesis i n vivo. IGF-I also stimulated growth in the cochleo-vestibular ganglio n. Binding of I-125-IGF-I to specific receptors occurred with high aff inity. An autoradiographic study of sections from otic vesicles showed radiolabeled IGF-I in the epithelium. Immunoreactivity to IGF-I was d etected in the otic vesicle and in the cochleo-vestibular ganglion. In tracellular signaling mechanisms of IGF were explored by studying the turnover of glycosylated phosphatidylinositols and the expression of F os oncoprotein. IGF-I rapidly increased Fos levels in cultured otic ve sicles. Furthermore, antisense oligonucleotides complementary to c-fos were able to inhibit IGF-I-induced growth. Both IGF-I-induced cell pr oliferation and Fos expression were blocked by an antiinositol phospho glycan (alpha-IPG) antibody. This work suggests that IGF-I may be a ca ndidate to regulate proliferative growth of the otic primordium during normal development and that this action requires the sequential modul ation of glycosyl-phosphatidylinositol turnover and Fos expression.